Best Business Magazines and News Online - CIO Bulletin

Elon Musk said he expects a wireless brain chip developed by his firm Neuralink to begin human clinical trials in six months after the firm missed his earlier timelines. Neuralink is developing brain chip interfaces that it says could enable disabled patients to move and communicate again, with Musk adding that the firm will also target restoring vision. Based in Austin, Texas, and the San Francisco Bay Area, Neuralink has in recent years been conducting tests on animals as it seeks approval from the US Food and Drug Administration (FDA) to start clinical trials in people. Continue reading

  Twitter Inc. sued billionaire Elon Musk for violating his $44 billion deal to purchase the microblogging platform. The firm asked a Delaware  court  to order the Tesla and SpaceX CEO to complete the merger. The complaint read Musk believed that he—unlike every other party subject to Delaware contract law—was free to change his mind, trash the firm, destroy stockholder value, disrupt its operations, and walk away scot-free. The litigation sets in motion what promises to be one of the most important legal face-offs in Wall Street history, concerning one of the business world’s most colorful entrepreneurs in a case that will turn on staid contract language. On July 8, Musk said he was terminating the deal because Twitter violated the agreement by failing to answer to requests for information regarding fake or spam accounts on the platform, which is fundamental to its business performance. The lawsuit accused Elon Musk of a long list of violations of the merger agreement th...